PMC6370068_01
Chest CT. (A) shows SD after 4 cycles of chemotherapy on December 15, 2016. (B) shows multiple pleural metastases on May 31, 2017. (C) shows SD after 5 months cabozantinib on November 9, 2017. (D) shows disease progression after 9 months cabozantinib in March 2017.
medi-98-e14120-g001.jpg
PMC6370068_01_medi-98-e14120-g001.jpg
F1
CT (Fig. 1A). Chemotherapy could not continue due to the poor tolerance of this patient. Multiple pleural metastases were revealed by chest CT (May 31, 2017) (Fig. 1B), indicating progressed disease (PD). Chest CTs were performed every 2 months, and SD continued (Fig. 1C) until March 2018 (Fig. 1D).